- Featured Product
- KD/KO Validated
Endoglin/CD105 Polyclonal antibody
Endoglin/CD105 Polyclonal Antibody for FC, IHC, IP, WB, ELISA
Cat no : 10862-1-AP
Validation Data Gallery
|Positive WB detected in||human placenta tissue|
|Positive IP detected in||mouse lung tissue|
|Positive IHC detected in||human breast cancer tissue, rat kidney tissue, human placenta tissue, human liver cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive FC detected in||THP-1 cells|
|Western Blot (WB)||WB : 1:500-1:1000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:200-1:1000 for WB|
|Immunohistochemistry (IHC)||IHC : 1:1000-1:4000|
|Sample-dependent, check data in validation data gallery|
10862-1-AP targets Endoglin/CD105 in WB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse, rat samples.
|Tested Reactivity||human, mouse, rat|
|Cited Reactivity||human, mouse, rat, Bovine|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Endoglin/CD105 fusion protein Ag1287|
|Calculated molecular weight||71 kDa|
|Observed molecular weight||75-90 kDa, 170-180 kDa|
|GenBank accession number||BC014271|
|Gene ID (NCBI)||2022|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
Endoglin (ENG, CD105) is a homodimeric cell membrane glycoprotein of 180 kDa, composed of disulphide-linked subunits of 90-95 kDa. Endoglin is a proliferation-associated and hypoxia-inducible protein mainly expressed on vascular endothelial cells. It acts as an accessory receptor for transforming growth factor beta (TFG-β) and is involved in vascular development and remodelling. The important role of Endoglin in angiogenesis and in tumor progression makes it an ideal target for antiangiogenic therapy and a good marker for tumor prognosis. (PMID: 1326540; 14528280; 21737653; 12773481)
|Product Specific Protocols|
|WB protocol for Endoglin/CD105 antibody 10862-1-AP||Download protocol|
|IHC protocol for Endoglin/CD105 antibody 10862-1-AP||Download protocol|
|IP protocol for Endoglin/CD105 antibody 10862-1-AP||Download protocol|
|FC protocol for Endoglin/CD105 antibody 10862-1-AP||Download protocol|
|Click here to view our Standard Protocols|
WISP2/CCN5 Suppresses Vasculogenic Mimicry through Inhibition of YAP/TAZ Signaling in Breast Cancer Cells.
Int J Biol Sci
Roquin2 suppresses breast cancer progression by inhibiting tumor angiogenesis via selectively destabilizing proangiogenic factors mRNA.
Endoglin Modulates TGFβR2 Induced VEGF and Proinflammatory Cytokine Axis Mediated Angiogenesis in Prolonged DEHP-Exposed Breast Cancer Cells.
Mol Hum Reprod
Oxidative stress-induced S100B protein from placenta and amnion affects soluble Endoglin release from endothelial cells.
World J Stem Cells
Quercetin ameliorates oxidative stress-induced senescence in rat nucleus pulposus-derived mesenchymal stem cells via the miR-34a-5p/SIRT1 axis
Exp Cell Res
Human umbilical cord mesenchymal stem cells regulate CD54 and CD105 in vascular endothelial cells and suppress inflammation in Kawasaki disease.